argenx SE (ARGNF)
OTCMKTS · Delayed Price · Currency is USD
547.60
+0.42 (0.08%)
At close: Jul 2, 2025
argenx SE Market Cap
argenx SE has a market cap or net worth of $36.30 billion as of July 30, 2025. Its market cap has increased by 30.03% in one year.
Market Cap
36.30B
Enterprise Value
32.74B
Revenue
2.64B
Ranking
n/a
PE Ratio
34.11
Stock Price
$547.60
Market Cap Chart
Since July 10, 2014, argenx SE's market cap has increased from 166.50M to 36.30B, an increase of 21,700.17%. That is a compound annual growth rate of 62.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2025 | 36.30B | -3.20% |
| Dec 31, 2024 | 37.50B | 67.18% |
| Dec 29, 2023 | 22.43B | 8.92% |
| Dec 30, 2022 | 20.59B | 11.15% |
| Dec 31, 2021 | 18.53B | 32.86% |
| Dec 31, 2020 | 13.95B | 102.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.81B |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 584.53M |
| Glass House Brands | 415.24M |
| Nika Pharmaceuticals | 366.89M |
| Northwest Biotherapeutics | 349.54M |
| CytoDyn | 341.59M |